Kymera Therapeutics (NASDAQ: KYMR) insider files to sell 6,206 RSU shares

Rhea-AI Filing Summary

Kymera Therapeutics, Inc. filed a Form 144 reporting intent to sell shares acquired on vesting of Restricted Stock Units. The filing lists 2,039 shares tied to RSUs vested on 03/01/2026 and 4,167 shares tied to RSUs vested on 03/03/2026.

The transactions are noted as equity compensation sales through a broker on or about those dates; the filing provides the share counts and vesting basis but does not state sale prices or proceeds.

Insights

Securities Counsel

Notice of proposed insider resale under Rule 144 for vested RSUs.

The filing lists intended dispositions of vested restricted stock units: 2,039 shares (vested 03/01/2026) and 4,167 shares (vested 03/03/2026), delivered via a broker-dealer.

Timing and pricing details are not included; subsequent Form 4 or broker reports may show executed trades.

Compensation Analyst

Vested RSUs being moved toward sale rather than retention.

The entries identify shares acquired upon RSU vesting under the 2020 Equity Incentive Plan and listed for resale in the aggregate shown on the cover. This reflects post-vesting disposition activity rather than new grants.

Impact on dilution is immaterial to capital structure as these are vested shares; further filings will clarify execution and proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC 1 New York Plaza 38th Floor New York NY 10004	6206	559161	81642394	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/01/2026	Shares acquired upon vesting of Restricted Stock Units awarded under the Issuer's 2020 Equity Incentive Plan.	KYMERA THERAPEUTICS, INC.			2039	03/01/2026	Equity compensation
Common Stock	03/03/2026	Shares acquired upon vesting of Restricted Stock Units awarded under the Issuer's 2020 Equity Incentive Plan.	KYMERA THERAPEUTICS, INC.			4167	03/03/2026	Equity compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did KYMR report in this Form 144?

The filing reports intent to sell vested RSU shares. It lists 2,039 shares vested on 03/01/2026 and 4,167 shares vested on 03/03/2026, reported as equity compensation transactions through a broker.

Does the Form 144 state sale prices or proceeds for KYMR shares?

No, the Form 144 lists share counts and vesting dates only. It does not disclose sale prices or aggregate proceeds; those details may appear in subsequent trade reports or broker confirmations.

Are the shares being sold newly issued or from vested RSUs for KYMR?

The shares are from vested Restricted Stock Units awarded under the 2020 Equity Incentive Plan. The filing identifies them as shares "acquired upon vesting" on the listed dates, not newly issued shares.

How many KYMR shares are included in the filing overall?

The filing shows a total of 6,206 shares listed for potential sale on the cover and in the securities table, consisting of the two RSU-related entries of 2,039 and 4,167.